Why Celldex Therapeutics, Inc. Fell on Monday [The Motley Fool]
Celldex Therapeutics, Inc. (CLDX)
Last celldex therapeutics, inc. earnings: 11/12 08:01 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.celldex.com
Company Research
Source: The Motley Fool
A big loss despite a lack of news for the precommercial biotech. Cory Renauer ( TMFang4apples ) Oct 22, 2018 at 3:18PM What happened Shares of Celldex Therapeutics, Inc. ( NASDAQ:CLDX ) , a clinical-stage biotech developing novel cancer therapies, fell 21.4% during midday trading on Monday despite a complete lack of news. As of 2:57 p.m. EDT, the stock was down 11.9%, possibly because investors were concerned the company had nothing worth mentioning to present this month's biggest oncology conference. So what Although it's hardly significant, investors can't be pleased with Celldex Therapeutics occupying a booth at the European Society of Medical Oncology's annual meeting over the weekend without sharing any new data. Although the company's former lead program cratered earlier this year, the company still has four candidates in clinical-sta
Show less
Read more
Impact Snapshot
Event Time:
CLDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLDX alerts
High impacting Celldex Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CLDX
News
- Celldex Therapeutics: Rising High, With Room For Further Growth [Seeking Alpha]Seeking Alpha
- Celldex Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
- Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.MarketBeat
- Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Celldex Reports First Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewswire
CLDX
Earnings
- 5/6/24 - Beat
CLDX
Sec Filings
- 5/6/24 - Form 10-Q
- 5/6/24 - Form 8-K
- 4/25/24 - Form ARS
- CLDX's page on the SEC website